Share Name Share Symbol Market Type Share ISIN Share Description
Ilika Plc LSE:IKA London Ordinary Share GB00B608Z994 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  4.50 7.5% 64.50 237,659 08:43:37
Bid Price Offer Price High Price Low Price Open Price
64.00 65.00 64.50 60.00 60.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Alternative Energy 0.50 -8.14 -4.65 102
Last Trade Time Trade Type Trade Size Trade Price Currency
08:45:58 O 756 64.8999 GBX

Ilika (IKA) Latest News

More Ilika News
Ilika Investors    Ilika Takeover Rumours

Ilika (IKA) Discussions and Chat

Ilika Forums and Chat

Date Time Title Posts
27/1/202315:56ILIKA - Multiple Material Opportunities!4,837
13/5/202207:47Ilika - First thread635
30/3/202219:47Ilika (IKA) One to Watch on Monday 28
03/3/201819:24Ilika plc (AIM: IKA)29

Add a New Thread

Ilika (IKA) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Ilika trades in real-time

Ilika (IKA) Top Chat Posts

Top Posts
Posted at 30/1/2023 08:20 by Ilika Daily Update
Ilika Plc is listed in the Alternative Energy sector of the London Stock Exchange with ticker IKA. The last closing price for Ilika was 60p.
Ilika Plc has a 4 week average price of 24p and a 12 week average price of 23.25p.
The 1 year high share price is 146.50p while the 1 year low share price is currently 23.25p.
There are currently 157,711,117 shares in issue and the average daily traded volume is 488,107 shares. The market capitalisation of Ilika Plc is £99,358,003.71.
Posted at 25/1/2023 07:48 by kenjen1
So is this the start of a new wave?

Last one took IKA into £2 and beyond. This will take time to determine but over the next year or so we could be looking at significant price above previous highs. Let’s see what the market does in the next few days. 63p anyone?

Posted at 17/1/2023 12:07 by shstt1
Rog the Deal will speed it up as Cirtec are experienced in manufacturing in this field and have a good reputation of bringing quickly to market, I think if it stayed with IKa it would be longer. So again I think you are wrong but heh if you want to waste your time posting on a company you don’t like and have no financial interest each to their own. You may have swayed some who knows but whilst you constantly bashed I made 40k last time.
JimmyAnn he has no holding here, he did for a time but made a loss selling at the wrong time and has been bitter since. That’s sad. He has only posted on this one thread for years so I guess he put all his eggs in one basket and got burned, so it kills him when the price rises. It’s plain as day, you see it a lot on these boards, some not letting go for years. Deary me.

Posted at 08/12/2022 12:25 by stix1
rogk/buzzthomas you are the ultimate Ilika super-troll! FWIW I think you have been right about most things IKA related going back to at least 2015. Lack of director investment here is a massive red flag to me and I see no prospect of any returns for anyone invested now. A sorry state of affairs. Glad I got out when I did and just about recovered my losses of several years at the time!
Posted at 15/11/2022 10:50 by kenjen1
Let’s be honest, the institutional investors thought they were getting a bargain at 140p. There is so much scope here for share price movement it’s not real. That won’t happen until management prove they have what it takes. Tick tock
Posted at 15/11/2022 08:25 by kenjen1
I agree this is about risk and reward. The challenge we may face is that the market has lost faith in current management. The tech is there no doubt. But the ability to commercialise may be beyond current team. They went to market at 1.40 for the placing, well below the then market price and promised stereax would be available in q2 22. They missed that deadline by miles! Not even close and still we wait. Who would trust this team now? The market doesn’t. Share price 47p. Shocking. Where is the new CFO that was meant to be brought in? Where is the update on stereax? Where are the Goliath customers? So many questions. So few answers. I totally belief in the science and the product they have but I don’t believe in the current management. Problem for me and many others is that we naively did believe in them and bought in at prices way higher than this. So what do we do, sell at a loss because the management can’t meet their own targets?
Posted at 14/11/2022 08:48 by phil2003
So.. in a nutshell NASA reveal they’ve been working on solid state battery tech for years, unprofitable, jam tomorrow, grant funded IKA no longer mentioned next to its contemporaries in this space and have a share price firmly on a pennant shaped downward trajectory with volumes confirming investors are loosing interest…

To invest or walk away with whatever money you have left here?
Not rocket science is it.

Posted at 14/8/2022 21:45 by clive7878
Both ALL and BHL in the same field had a recomendation and a rise in share price
but has now fallen back quite a bit, will ITA buck the trend.

lithium has apparently gone up about 5 times but these companies need to make money for the share price to rise - not just hot air and hope.

Posted at 13/7/2022 18:02 by horneblower
"IKA always very careful with their words..."

Indeed, they speak much but say almost nothing.

e.g. from today's RNS:

"Patent Position
Building Ilika's intellectual property portfolio in solid-state batteries has continued to be a focus this year. Ilika believes its patents ring-fence and protect critical IP to avoid competitors working around a single patent. Ilika now maintains a portfolio of 25 granted patents, as well as trade secrets in solid-state batteries."

Actally, nearly all the patents are from years ago. The most recent, granted April '22, was first filed in 2017.

Interesting that they talk about trade secrets. What are these? It's all smoke and mirrors.

"Ilika is developing low-cost printing processes suitable for manufacturing solid state batteries several orders of magnitude larger than miniature Stereax batteries."

More bs. It's screen-printing. Why not call it so?

Posted at 11/5/2022 11:15 by firestorm911
Was a red flag.

21/03/2022 11:45am
UK Regulatory (RNS & others)

Ilika (LSE:IKA)
Historical Stock Chart

From Mar 2022 to May 2022

Click Here for more Ilika Charts.

RNS Number : 4521F

Ilika plc

21 March 2022

Ilika plc

("Ilika" or the "Company")

Director/PDMR Shareholding

Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces that between 18 March and 21 March 2022, Steve Boydell, CFO, sold an aggregate of 371,222 shares at an average price of 109p per share. This completes the planned sale of shares resulting from the option exercise announced on 8 March 2022.

Posted at 14/12/2021 08:52 by tp5588
Posted on another site. Credit to original poster:

"Thoughts on Investor Day and Site Visit

The company has changed a lot since my last site visit (pre-Covid) and is clearly gearing up for commercialisation of their world beating intellectual property. Overall, I was very impressed with progress.

Ilika was founded on the back of ground breaking scientific research headed by Prof. Brian Hayden. He and his team have taken the science forward through advanced engineering (Tool 1 and Tool 2 were made bespoke to Ilika’s designs for example) towards commercial reality. My top take-away was that the Ilika’s management are now also adding focus and resources towards commerciality.

Most of the traffic on bulletin boards about Ilika seems to be focussed on Goliath (batteries for EV’s). Whilst there was a very full update on Goliath progress (and a tour of the new Goliath Research and Development laboratories), which is going very well (the analysts at Liberum and Berenberg both agreed that none of the big name Goliath competitors were ahead of Ilika in terms of that technology, although they are vastly higher market valuations), I will concentrate this write up on Stereax as it will be the driver of nearer term sales revenue and seems to be less well understood. Bear in mind Ilika are in many ways creating the market through the imminent availability of Stereax batteries in quantities which will allow incorporation in commercial products.

The new(ish) VP of Sales and Marketing, John Tinson was clearly out of the highest of top drawers. It was clear that Ilika are determined to nurture their client base (recall ~27 med tech device makers and 11 Internet of Things sensor makers have already been buying Ilika’s Stereax batteries for evaluation, re-certification and research and development purposes). Through his presentation and in Q&A, it was quite obvious that he understood in great detail Stereax’s market segmentation and the price inelastic nature of demand from Med Tech in particular. Tinson made clear that given the limited ability for Ilika to supply in the short term (FAB1 will be able to produce ~£13 mio worth of batteries per annum) that Ilika will be exploiting their understanding of the market for Ilika’s commercial gain.

Ilika also hired another Sales VP (who also had an impressive background and who presented very well, but whose name I can’t recall – this is my lack not his; he was equally impressive as John Tinson). Through these extremely high quality hires, it is apparent that Graeme Purdy and his top management team are focussed on turning their scientific and engineering excellence into profits for the shareholders, whilst retaining a leading position in what will be a very rapidly growing market place for nano-scale batteries.

As previously advised by the company (and in line with stock exchange rules) no market sensitive information was given. No doubt some PIs foolishly bought in anticipation of the investor day and are now dumping those (tiny) holdings. Frankly, I am sure that long term shareholders would rather not have such myopic people on the share register (which is now over 15% US based according to Steve Boydell CFO).

Having said that, personally I think they will be announcing a full year ahead orderbook not long after product validation (which will happen after process validation, as confirmed by Paul Marron, who was clearly totally on top of the production process at FAB1).

They are also currently evaluating the relative merits of increasing capacity at FAB1, bringing in-house the rest of the many processes (thinning and dicing for instance) of Stereax production and FAB2 (for which there is space next door…). Recall that the cost of FAB2 was already raised in the May 2020 fund raise (which I am glad to have taken part in).

If there is an area of weakness, it was in my opinion their ham-fisted fund-raise of ~£25 mio for Goliath at a 30% discount to the prevailing market. If they needed the money (which they did; in comparison QuantumScape are making losses greater than the entire market capitalisation of Ilika in less than 3 months, every 3 months ...), they should have raised when the share price was rising above £2.75 less than 6 months earlier. This would have resulted in greater funds at lesser dilution. However, that is now in the past and the money at least has been raised and is being put to extremely efficient use.

In summary, we already knew that Brian Hayden and his team were world leaders in terms of the tech (both the chemistry and in overcoming engineering problems to turn the science into commercially viable product). The shift of focus to commerciality was definitely needed, but the quality of their hiring shows just how able to evolve this Management team are. They will need to follow this up with results next financial year in terms of Sales and scale-up plans in order to continue to show their effectiveness.

I am delighted with their approach of setting realistic guidance and delivering it (rather than making wild claims to gather attention, and then failing to deliver, which any student of the history of the battery industry will know it is littered with). The future looks extremely bright for long term Ilika shareholders imo."

Ilika share price data is direct from the London Stock Exchange
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230130 09:02:27